Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
27 04 2022
Historique:
pubmed: 1 3 2022
medline: 30 4 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

SARS-CoV-2 coronavirus is a recently identified novel coronavirus that is the causative agent of the COVID-19 pandemic that began in 2020. An intense research effort has been undertaken by the research community in order to better understand the molecular etiology of this virus and its mechanisms of host cell subjugation and immune system evasion. To facilitate further research into the SARS-CoV-2 coronavirus we have generated adenovirus 5-based viral vectors that express SARS-CoV-2 proteins-S, N, E, NSP7, NSP8, and NSP12 as hemagglutinin (HA)-tagged and untagged variants. We have also engineered two additional viruses that express the S protein receptor binding domain and a fusion of the receptor binding domain to the N protein. We show that these vectors are expressed in several different cell lines by Western blotting and real-time quantitative reverse transcriptase (qRT-PCR), we evaluate the subcellular localization of these viral proteins, and we show that these coronavirus proteins bind to a variety of cellular targets. The flexibility of adenovirus vectors allows them to be used in a variety of cell models and, importantly, in animal models as well.

Identifiants

pubmed: 35224978
doi: 10.1128/msphere.00998-21
pmc: PMC9044955
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0099821

Subventions

Organisme : CIHR
ID : PJT-173376
Pays : Canada
Organisme : CIHR
ID : PJT-166198
Pays : Canada

Références

N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Virol. 2015 Dec 16;90(4):1931-43
pubmed: 26676776
Cell Mol Immunol. 2021 Apr;18(4):945-953
pubmed: 33637958
Hum Vaccin Immunother. 2016 Aug 2;12(8):2064-2074
pubmed: 27105067
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Bioinform Biol Insights. 2021 Jun 22;15:11779322211025876
pubmed: 34220199
Gene Ther. 2007 Sep;14(17):1298-304
pubmed: 17597793
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Virol J. 2019 May 27;16(1):69
pubmed: 31133031
J Virol. 1997 Mar;71(3):1842-9
pubmed: 9032314
J Virol. 1995 Aug;69(8):4600-6
pubmed: 7609024
Proc Soc Exp Biol Med. 1953 Dec;84(3):570-3
pubmed: 13134217
J Med Virol. 2022 Apr;94(4):1366-1372
pubmed: 34890492
Emerg Infect Dis. 2020 Sep;26(9):2054-2063
pubmed: 32558639
J Virol. 2021 Feb 24;95(6):
pubmed: 33361423
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Viruses. 2020 Feb 14;12(2):
pubmed: 32075072
Int J Biol Sci. 2020 Mar 15;16(10):1678-1685
pubmed: 32226285
Respir Res. 2020 Dec 1;21(1):318
pubmed: 33261606
Can J Microbiol. 2021 Mar;67(3):189-212
pubmed: 33264067

Auteurs

Scott Bachus (S)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Nikolas Akkerman (N)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Lauren Fulham (L)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Drayson Graves (D)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Caelan Stephanson (C)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Harram Memon (H)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Matthew S Miller (MS)

Michael G. DeGroote Institute for Infectious Disease Research, McMaster Universitygrid.25073.33, Hamilton, Ontario, Canada.

Peter Pelka (P)

Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH